FDA product code QZI: Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation

QZI is the FDA product code for percutaneous cardiac ablation catheter for treatment of atrial fibrillation with irreversible electroporation. It is a Class III device, reviewed by the Cardiovascular panel. Devices under QZI reach the market by PMA; FDA lists no cleared 510(k)s for it. 6 PMA applications cite this product code. FDA has posted 6 recalls for QZI devices, 6 initiated in the last five years.

Definition

For the treatment of atrial fibrillation.

Classification

FieldValue
Device namePercutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation
Device classClass III
Review panelCV — Cardiovascular
Medical specialtyUnknown
Premarket routePMA

Recalls for QZI devices

6 product recalls in 4 recall events; 6 initiated in the last five years and 5 still open. Most recent: 2026-06-11.

YearRecalls
20252
20264

Frequently asked questions

What is FDA product code QZI?

QZI is the FDA product code for percutaneous cardiac ablation catheter for treatment of atrial fibrillation with irreversible electroporation. It is a Class III device, reviewed by the Cardiovascular panel.

What device class is QZI?

Class III. Typical premarket route: PMA.

Have QZI devices been recalled?

Yes: 6 product recalls across 4 recall events; the most recent began 2026-06-11.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times